Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Robert Blum

Some businesses are now backtracking on DEI. Biopharma cannot afford to and must remain resolute

(Credit: Getty Images)

A year ago, the United States Supreme Court eliminated affirmative action from higher education. The controversial ruling immediately prompted widespread backlash and raised numerous questions about its potentially chilling effect on diversity, equity, and inclusion (DEI) programs in corporate America. And since that decision, the rhetoric surrounding the issue has only become more divisive and dangerous. It is essential that executives, especially in the health care industry, push back and protect the care of our patients, the integrity and quality of which depends on our truly diverse and inclusive organizations. 

A group of Republican lawmakers recently introduced legislation to end all DEI programs within the federal government. Senator Bill Cassidy claimed that “DEI institutionalized discrimination in hiring.” Senator J.D. Vance asserted that the “DEI agenda is a destructive ideology that breeds hatred and racial division” and insisted, “Americans’ tax dollars should not be co-opted to spread this radical and divisive ideology.”

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.